Professor Andrew Jamieson is Professor of Chemical Biology at the University of Glasgow, UK. He obtained a 1st Class degree in Chemistry with Medicinal Chemistry (placement with the Sir James Black Foundation) and PhD from the University of Glasgow (2007). He completed post-doctoral fellowships at the University of Montreal with Prof William Lubell and then with Prof Andrew Hamilton FRS at Yale University and then the University of Oxford. His research during this time focused on the development of bio-organic chemistries to produce novel peptidomimetics for chemical biology. Andrew then joined the faculty at the University of Leicester, UK in 2010 where he initiated a research programme, funded by EPSRC, focused on the development of novel conformationally constrained peptidomimetics. In 2016 he moved to the University of Glasgow as a Senior lecturer, was promoted to Reader in 2019 and to Professor in 2022. He leads a research group, currently funded by EPSRC, MRC and the Department of Defense, Defence Treat Reduction Agency, focused on the design and synthesis of chemical tools that can be used to probe the biological mechanisms underpinning disease.

Andrew has extensive leadership experience in delivering multidisciplinary research projects and knowledge exchange with industrial partners. He is founding Director of Keltic Pharma Therapeutics (keltic-pharma.com), a University of Glasgow Spin out company focused on the delivery of a novel anti-malarial treatment and new receptor-based medicines. He chaired the Royal Society of Chemistry (RSC) Chemical Biology and Bio-Organic Group (2017-2020) and currently sits on the RSC Organic Chemistry Community (formally Division) Council as an elected member with responsibility for promoting scientific excellence, interdisciplinary collaborations and supporting early career scientists in the research community.

Andrew was recently awarded the 2023 RSC Chemical Biology and Bio-Organic Chemistry Lectureship ‘for his outstanding contribution to the chemical biology community and his exceptional research achievements on the design and syntheses of peptides and peptidomimetics for chemical biology applications.’